Page last updated: 2024-08-17

levodopa and Anochlesia

levodopa has been researched along with Anochlesia in 81 studies

Research

Studies (81)

Timeframe	Studies, this research(%)	All Research%
pre-1990	27 (33.33)	18.7374
1990's	22 (27.16)	18.2507
2000's	12 (14.81)	29.6817
2010's	18 (22.22)	24.3611
2020's	2 (2.47)	2.80

Authors

Authors	Studies
Ginos, JZ; Nichols, DE; Stevens, JM	1
Ahmed, MA; Alkskas, IA; Azam, F	1
Belozertseva, IV; Dorotenko, A; Efimova, EV; Fesenko, Z; Gainetdinov, RR; Mor, MS; Savchenko, A; Sotnikova, TD; Sukhanov, I	1
Guerrero, MF; López, JL; Olaya, MDP; Vergel, NE; Viña, MD	1
Adekenov, SM; Arystan, LI; Haydargalieva, LS; Muldaeva, GM; Nurmaganbetov, ZS	1
Khurana, N; Muthuraman, A; Sharma, N; Utreja, P	1
Ikram, R; Riaz, B; Sikandar, B	1
Gupta, S; Patel, RK; Sharma, AK; Wardhan, N	1
Khan, SS; Mirza, T; Naeem, S; Najam, R; Sikandar, B	1
Borrelli, E; Calcagno, M; Marti, M; Morari, M; Viaro, R	1
Bleickardt, C; Hodgson, R; Jones, N; Mullins, D; Parker, E	1
Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T; Lorenc-Koci, E	1
Bubser, M; Cenci, MA; Conn, PJ; Hopkins, CR; Iderberg, H; Jones, CK; Lindsley, CW; Maslava, N; Niswender, CM; Thompson, AD	1
Bardin, L; Cenci, MA; Depoortère, R; Iderberg, H; Kleven, MS; Koek, W; McCreary, AC; Newman-Tancredi, A; Varney, MA	1
Ivanova, EA; Kapitsa, IG; Val'dman, EA; Voronina, TA	1
Khatoon, H; Mirza, T; Najam, R; Sikandar, B	1
Barodia, SK; Luthra, PM; Raghubir, R	1
Dziubina, A; Gołembiowska, K; Kamińska, K; Kowalska, M	1
Bateup, HS; Birnbaum, S; Fisone, G; Greengard, P; Nestler, EJ; Santini, E; Shen, W; Surmeier, DJ; Valjent, E	1
Babapour, V; Mahmoudi, J; Nayebi, AM; Reyhani-Rad, S; Samini, M	1
Amalric, M; Blobaum, AL; Bode, J; Bridges, TM; Bubser, M; Conn, PJ; Daniels, JS; Dickerson, JW; Engers, DW; Hopkins, CR; Italiano, K; Jadhav, S; Jones, CK; Lindsley, CW; Morrison, RD; Niswender, CM; Thompson, AD; Turle-Lorenzo, N	1
Bacolod, MD; Bennouar, KE; Cajina, M; Doller, D; Gubellini, P; Jimenez, HN; Kerkerian-Le Goff, L; Melon, C; Uberti, MA	1
Ionov, ID; Severtsev, NN	1
Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F	1
Kulkarni, SK; Naidu, PS; Singh, A	2
Alam, M; Mayerhofer, A; Schmidt, WJ	1
Schmidt, WJ; Srinivasan, J	1
Cristalli, G; Morelli, M; Pinna, A; Volpini, R	1
Ding, JH; Hu, G; Liu, SY; Liu, X; Long, Y; Sun, YH; Wang, F; Wang, H; Wu, J; Yang, Y; Yao, HH	1
Eltayb, A; Svensson, TH; Wadenberg, ML	1
Cenci, MA; Danysz, W; Dekundy, A; Pietraszek, M; Schaefer, D	1
Klusha, VE; Kozlovskaia, MM; Svirskis, ShV; Val'dman, AV	1
Chiu, S; Mishra, RK	1
Maeno, H; Tachikawa, S; Usuda, S; Yamamoto, M	1
Balsara, JJ; Chandorkar, AG; Gada, VP; Nandal, NV	1
Malone, MH; Namba, MM; Quock, RM	2
Ikoma, H; Kikumoto, R; Tobe, A; Tonomura, S; Yoshida, Y	1
Baran, L; Przegaliński, E	1
Dawbarn, D; O'Shaughnessy, C; Pycock, C	1
Ossowska, K	1
Schmidt, WJ; Zadow, B	1
Himori, N; Mishima, K	1
Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F	1
Carruba, MO; da Prada, M; Imhof, R; Nisoli, E; Scherschlicht, R; Tonello, C	1
Maj, J; Rogóz, Z; Skuza, G	2
Akaike, N; Himori, N; Kurasawa, M; Mishima, K; Tanaka, Y	1
Baĭchurina, AZ; Garaev, RS; Semina, II	1
Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G	1
Pergande, G; Schmidt, WJ; Schuster, G; Wacker, E	1
Araki, T; Itoyama, Y; Kobayashi, T; Ohta, T; Oshima, Y; Takeshita, M	1
Danysz, W; Karcz-Kubicha, M; Lorenz, B	1
de Ceballos, ML; Fontenla, JA; Nieto, O; Rivas, E	1
Asmakova, LS; Bondarenko, NA; Gudasheva, TA; Kalinina, TS; Ostrovskaya, RU; Seredenin, SB; Voronina, TA; Zaitseva, NI	1
Ichikawa, S; Kitamura, S; Kuwana, Y; Nakamura, J; Shiozaki, S; Yamada, K	1
Chambers, LK; Greenamyre, JT; Jaw-Tsai, SS; Menniti, FS; Steece-Collier, K	1
Fuenmayor, LD; Vogt, M	1
Chrétien, M; Motomatsu, T; Seidah, N	1
Eshel, Y; Korczyn, AD	1
Boucher, R; Dankova, J; Larochelle, L; Péchadre, JC; Poirier, LJ	1
Baran, L; Maj, J; Sowińska, H	1
Korobov, NV; Uspenskiĭ, AE	1
Fujiwara, M; Inoue, K; Ueki, S	1
Shore, PA	1
Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S	1
Hotta, K; Mizusawa, H; Morita, S; Nagase, T; Omote, M; Sakai, K; Yamane, M	1
Onodera, K; Shinoda, H	1
el-Sawaf, HA; Puri, VN; Rao, KV	1
Maj, J; Rogóz, Z; Skuza, G; Sowińska, H; Superata, J	1
Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM	1
Elazar, Z; Ganchrow, D; Korczyn, AD; Paz, M; Paz, Z; Rabinowitz, R	1
Fujiwara, M; Kamiya, H; Ono, N; Saito, R	1
Kaakkola, S; Männistö, PT; Nuutila, J	1
Bhattacharya, SK; Parmar, SS	1
Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P	1
Barnes, JC; Barnes, NJ; Barnes, NM; Costall, B; Domeney, AM; Naylor, RJ	1
Hashimoto, T; Koda, H; Kuriyama, K	1
Algeri, S; Olgiati, VR; Stramentinoli, G	1
Aizenstein, ML; de-Lucia, R; Scavone, C; Steinschreiber, S	1

Reviews

1 review(s) available for levodopa and Anochlesia

Article	Year
The role of excitatory amino acids in experimental models of Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1994, Volume: 8, Issue:1-2 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Catalepsy; Disease Models, Animal; Excitatory Amino Acids; Levodopa; N-Methylaspartate; Oxidopamine; Parkinson Disease; Rats	1994

Other Studies

80 other study(ies) available for levodopa and Anochlesia

Article	Year
Structure--activity relationships of n-substituted dopamine and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene analogues: behavioral effects in lesioned and reserpinized mice. Journal of medicinal chemistry, 1979, Volume: 22, Issue:11 Topics: Animals; Behavior, Animal; Catalepsy; Dopamine; Humans; Male; Mice; Naphthalenes; Posture; Reserpine; Structure-Activity Relationship; Tetrahydronaphthalenes	1979
Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice. European journal of medicinal chemistry, 2009, Volume: 44, Issue:10 Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Brain; Catalepsy; Glutathione; Glutathione Peroxidase; Haloperidol; Male; Malondialdehyde; Mice; Oxidative Stress; Parkinson Disease; Pyrimidines; Superoxide Dismutase; Thiourea; Urea	2009
Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson's Disease Therapy. Biomolecules, 2022, 12-21, Volume: 13, Issue:1 Topics: Animals; Carbidopa; Catalepsy; Dopamine; Levodopa; Parkinson Disease; Rats	2022
Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent Biomedica : revista del Instituto Nacional de Salud, 2019, 09-01, Volume: 39, Issue:3 Topics: Animals; Antiparkinson Agents; Carbidopa; Catalepsy; Coumarins; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Locomotion; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Reserpine	2019
Experimental study of antiparkinsonian action of the harmine hydrochloride original compound. Pharmacological reports : PR, 2019, Volume: 71, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Catalepsy; Haloperidol; Harmine; Levodopa; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Rats	2019
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model. European journal of pharmacology, 2021, Jul-15, Volume: 903 Topics: Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Body Weight; Carbidopa; Catalase; Catalepsy; Disease Models, Animal; Dopamine; Drug Combinations; Female; Glutathione; Levodopa; Locomotion; Male; Mesencephalon; Muscular Diseases; Oxidative Stress; Parkinson Disease; Postural Balance; Rats, Sprague-Dawley; Rotenone; Superoxides; Thiobarbituric Acid Reactive Substances; Vanillic Acid	2021
Anticataleptic activity of Zamzam water in chlorpromazine induced animal model of Parkinson disease. Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:2 Topics: Animals; Brain; Carbidopa; Catalepsy; Chlorpromazine; Disease Models, Animal; Drug Combinations; Hydrogen-Ion Concentration; Levodopa; Parkinsonian Disorders; Rats; Water	2018
Haloperidol-induced parkinsonism is attenuated by varenicline in mice. Journal of basic and clinical physiology and pharmacology, 2018, Jul-26, Volume: 29, Issue:4 Topics: Animals; Catalepsy; Disease Models, Animal; Dopamine; Female; Haloperidol; Levodopa; Male; Mice; Neurons; Parkinsonian Disorders; Varenicline	2018
Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats. Metabolic brain disease, 2019, Volume: 34, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Catalepsy; Chlorpromazine; Corpus Striatum; Diclofenac; Dopamine; Female; Levodopa; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar	2019
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands. Neuropharmacology, 2013, Volume: 72 Topics: Analgesics, Opioid; Animals; Carbamates; Catalepsy; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Levodopa; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morphine; Motor Activity; Nociceptin; Opioid Peptides; Receptors, Dopamine D2; Rotarod Performance Test	2013
A2A receptor antagonists do not induce dyskinesias in drug-naive or L-dopa sensitized rats. Brain research bulletin, 2013, Volume: 98 Topics: Adenosine A2 Receptor Antagonists; Adrenergic Agents; Analysis of Variance; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors	2013
Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra. Behavioural brain research, 2014, Mar-15, Volume: 261 Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Adrenergic Agents; Animals; Antiparkinson Agents; Apomorphine; Catalepsy; Cysteine Proteinase Inhibitors; Dopamine Agonists; Dose-Response Relationship, Drug; Functional Laterality; Levodopa; Male; Oxidopamine; Rats; Rats, Wistar; Reaction Time; Serotonin; Substantia Nigra	2014
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Neuropharmacology, 2015, Volume: 95 Topics: Aminobutyrates; Animals; Antiparkinson Agents; Catalepsy; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agents; Haloperidol; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Phosphinic Acids; Picolinic Acids; Random Allocation; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate	2015
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat. Experimental neurology, 2015, Volume: 271 Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Brain; Catalepsy; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Female; Haloperidol; Levodopa; Movement; Neurotransmitter Agents; Oxidopamine; Piperidines; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin Syndrome; Swimming; Vocalization, Animal	2015
Anti-Parkinsonian Activity of Hemantane on a Model of Hemiparkinsonian Syndrome in Rats. Bulletin of experimental biology and medicine, 2015, Volume: 159, Issue:3 Topics: Adamantane; Animals; Antiparkinson Agents; Catalepsy; Levodopa; Male; Rats; Rats, Wistar	2015
Beneficial anti-Parkinson effects of camel milk in Chlorpromazineinduced animal model: Behavioural and histopathological study. Pakistan journal of pharmaceutical sciences, 2016, Volume: 29, Issue:5 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Brain; Camelus; Carbidopa; Catalepsy; Chlorpromazine; Drug Combinations; Female; Levodopa; Male; Milk; Parkinsonian Disorders; Rats, Wistar; Time Factors	2016
Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease. Journal of neuroscience methods, 2009, Apr-15, Volume: 178, Issue:2 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Caffeine; Catalepsy; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutathione; Haloperidol; Levodopa; Male; Mice; Motor Activity; Parkinsonian Disorders; Posture; Superoxide Dismutase; Swimming	2009
Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum. Neurotoxicity research, 2009, Volume: 15, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Area Under Curve; Benserazide; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Homovanillic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Rats; Rats, Wistar; Time Factors; Triazines; Triazoles; Xanthines	2009
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proceedings of the National Academy of Sciences of the United States of America, 2010, Aug-17, Volume: 107, Issue:33 Topics: Animals; Catalepsy; Cocaine; Corpus Striatum; Dopamine Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Female; Fluorescent Antibody Technique; Green Fluorescent Proteins; Haloperidol; Immunohistochemistry; Levodopa; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Motor Activity; Neuronal Plasticity; Neurons; Synaptic Potentials	2010
Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats. Pharmacological reports : PR, 2011, Volume: 63, Issue:4 Topics: Animals; Antiparkinson Agents; Buspirone; Catalepsy; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Serotonin 5-HT1 Receptor Agonists; Time Factors	2011
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2012, Volume: 340, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Brain; Calcium Signaling; Catalepsy; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Levodopa; Male; Monoamine Oxidase; Motor Neuron Disease; Oxidopamine; Parkinson Disease; Picolinic Acids; Protein Binding; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Metabotropic Glutamate; Substantia Nigra; Thallium; Transfection; Triazoles; Tyrosine 3-Monooxygenase	2012
Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia. Neuropharmacology, 2013, Volume: 66 Topics: Allosteric Regulation; Aminobutyrates; Anilides; Animals; Catalepsy; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Haloperidol; Levodopa; Male; Oxidopamine; Parkinson Disease; Phosphinic Acids; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission	2013
Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA. Psychopharmacology, 2012, Volume: 223, Issue:2 Topics: Aging; Animals; Antiparkinson Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Mice, Inbred BALB C; Parkinson Disease; Time Factors	2012
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice. Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:2 Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine Agonists; Food, Formulated; Levodopa; Magnesium; Magnesium Deficiency; Male; Mice; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase	2013
Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition. Pharmacology, 2003, Volume: 68, Issue:2 Topics: Animals; Antiparkinson Agents; Catalepsy; Catechol O-Methyltransferase Inhibitors; Levodopa; Male; Monoamine Oxidase Inhibitors; Perphenazine; Quercetin; Rats; Rats, Wistar; Reserpine	2003
The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA. Behavioural brain research, 2004, May-05, Volume: 151, Issue:1-2 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Brain Chemistry; Catalepsy; Chromatography, High Pressure Liquid; Dopamine; Levodopa; Male; Medial Forebrain Bundle; Motor Activity; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Reaction Time; Rotenone; Statistics, Nonparametric; Time Factors	2004
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Behavioural brain research, 2004, May-05, Volume: 151, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Benzylamines; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Locus Coeruleus; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Statistics, Nonparametric; Tyrosine	2004
FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats. Indian journal of experimental biology, 2003, Volume: 41, Issue:11 Topics: Animals; Antiparkinson Agents; Catalepsy; Drug Therapy, Combination; Female; Immunosuppressive Agents; Levodopa; Male; Rats; Rats, Wistar; Reserpine; Tacrolimus	2003
New adenosine A2A receptor antagonists: actions on Parkinson's disease models. European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3 Topics: Adenine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Drug Synergism; Levodopa; Male; Molecular Structure; Parkinson Disease; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tritium	2005
Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:1 Topics: Animals; Antiparkinson Agents; Basal Ganglia; Catalepsy; Decanoic Acids; Diazoxide; Disease Models, Animal; Dopamine; Hydroxy Acids; Levodopa; Male; Motor Activity; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Parkinsonian Disorders; Potassium Channel Blockers; Potassium Channels; Propylamines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotenone; Substantia Nigra	2006
Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa. Biological psychiatry, 2005, Aug-15, Volume: 58, Issue:4 Topics: Analysis of Variance; Animals; Avoidance Learning; Benserazide; Catalepsy; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Levodopa; Male; Microdialysis; Nucleus Accumbens; Prefrontal Cortex; Raclopride; Rats; Rats, Wistar; Time Factors	2005
Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. Brain research bulletin, 2006, Apr-14, Volume: 69, Issue:3 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Functional Laterality; Haloperidol; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rotarod Performance Test; Thiazoles; Time Factors	2006
[Psychopharmacologic spectrum of melanostatin]. Biulleten' eksperimental'noi biologii i meditsiny, 1980, Volume: 89, Issue:6 Topics: Aggression; Amantadine; Animals; Behavior, Animal; Biogenic Amines; Brain Chemistry; Catalepsy; Cats; Depression; Emotions; Fever; Haloperidol; Humans; Levodopa; Motor Activity; MSH Release-Inhibiting Hormone; Reserpine	1980
Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy. Naunyn-Schmiedeberg's archives of pharmacology, 1980, Volume: 313, Issue:1 Topics: Animals; Apomorphine; Catalepsy; Dose-Response Relationship, Drug; Humans; Levodopa; Lysergic Acid Diethylamide; Male; MSH Release-Inhibiting Hormone; Naloxone; Parasympathomimetics; Rats; Synaptic Transmission; Time Factors	1980
Pharmacological studies on a new benzamide derivative, YM-09151-2, with potential neuroleptic properties. Neuropharmacology, 1982, Volume: 21, Issue:10 Topics: Amygdala; Animals; Antipsychotic Agents; Benzamides; Catalepsy; Cats; Caudate Nucleus; Electroencephalography; Female; Humans; Levodopa; Male	1982
Psychopharmacological investigation of the monoamine oxidase inhibitory activity of molindone, a dihydroindolone neuroleptic. The Journal of pharmacy and pharmacology, 1984, Volume: 36, Issue:9 Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Behavior, Animal; Blepharoptosis; Catalepsy; Fenclonine; Fenfluramine; Humans; Indoles; Levodopa; Male; Mice; Molindone; Monoamine Oxidase Inhibitors; p-Chloroamphetamine; Rats; Reserpine; Stereotyped Behavior; Tryptamines; Tryptophan	1984
Narcotic antagonist potentiation of L-DOPA in the reversal of reserpine induced catalepsy. Proceedings of the Western Pharmacology Society, 1980, Volume: 23 Topics: Animals; Catalepsy; Drug Synergism; Humans; Levodopa; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Reserpine; Time Factors	1980
Effects of narcotic antagonists on L-dopa reversal of reserpine-induced catalepsy and blepharoptosis in mice. Life sciences, 1981, Apr-06, Volume: 28, Issue:14 Topics: Animals; Blepharoptosis; Catalepsy; Drug Antagonism; Drug Synergism; Humans; Kinetics; Levodopa; Male; Mice; Naloxone; Naltrexone; Reserpine	1981
Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity. Arzneimittel-Forschung, 1981, Volume: 31, Issue:8 Topics: Aggression; Animals; Antidepressive Agents; Behavior, Animal; Benzhydryl Compounds; Catalepsy; Catecholamines; Cats; Drug Interactions; Female; Humans; Levodopa; Male; Methamphetamine; Mice; Parasympatholytics; Rats; Reserpine; Stereotyped Behavior; Tetrabenazine; Yohimbine	1981
Psychopharmacological profile of mesterolone. Polish journal of pharmacology and pharmacy, 1981, Volume: 33, Issue:3 Topics: Animals; Behavior, Animal; Body Temperature; Catalepsy; Dihydrotestosterone; Humans; Levodopa; Male; Mesterolone; Mice; Motor Activity; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior	1981
Behavioural and biochemical changes following chronic administration of L-dopa to rats. European journal of pharmacology, 1982, Apr-23, Volume: 79, Issue:3-4 Topics: Adenylyl Cyclases; Amphetamine; Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; Catalepsy; Diet; Female; Humans; Levodopa; Motor Activity; Rats; Receptors, Dopamine; Stereotyped Behavior	1982
The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy. Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 349, Issue:1 Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Drug Interactions; Ergolines; Haloperidol; Levodopa; Male; Pilot Projects; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA	1994
The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice. Experientia, 1994, Oct-15, Volume: 50, Issue:10 Topics: 1-Methyl-4-phenylpyridinium; Animals; Benserazide; Benzophenones; Catalepsy; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Synergism; Haloperidol; Kinetics; Levodopa; Male; Mice; Mice, Inbred C57BL; Nitrophenols; Tolcapone; Tyrosine	1994
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. European journal of pharmacology, 1994, May-02, Volume: 256, Issue:3 Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines	1994
Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1 Topics: 4-Butyrolactone; Adenylyl Cyclases; Amphetamine; Animals; Apomorphine; Biogenic Monoamines; Brain; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Motor Activity; Perfusion; Potassium; Quinolines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Serotonin; Stereotyped Behavior; Synapses; Tetrahydronaphthalenes; Time Factors; Tritium	1993
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 6, Issue:1 Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase	1993
3-O-methyldopa attenuates the effects of Madopar on the haloperidol-induced cataleptic behavior and the locomotor activity in the mouse. Pharmacology, 1994, Volume: 48, Issue:4 Topics: Animals; Benserazide; Catalepsy; Drug Combinations; Haloperidol; Levodopa; Male; Mice; Motor Activity; Tyrosine	1994
[The effect on central dopaminergic structures of various hydrazides of phosphorylated carbonic acids and diaziridines]. Biulleten' eksperimental'noi biologii i meditsiny, 1996, Volume: 121, Issue:6 Topics: Acetates; Animals; Apomorphine; Body Temperature; Catalepsy; Dopamine Agents; Drug Interactions; Haloperidol; Hydrazines; Levodopa; Mice; Stereotyped Behavior	1996
The behavioural effects of pramipexole, a novel dopamine receptor agonist. European journal of pharmacology, 1997, Apr-11, Volume: 324, Issue:1 Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles	1997
Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs. European journal of pharmacology, 1997, May-26, Volume: 327, Issue:1 Topics: Aminopyridines; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Dextroamphetamine; Dose-Response Relationship, Drug; Grooming; Levodopa; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate	1997
Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice. Life sciences, 1997, Volume: 61, Issue:26 Topics: Animals; Bromocriptine; Carbidopa; Catalepsy; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Motor Activity	1997
GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist. Neuropharmacology, 1999, Volume: 38, Issue:1 Topics: Animals; Antiparkinson Agents; Binding, Competitive; Catalepsy; Cyclopentanes; Drug Evaluation, Preclinical; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine Agents; Haloperidol; Hypnotics and Sedatives; Levodopa; Male; Neuroprotective Agents; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reserpine	1999
In vivo effects of new inhibitors of catechol-O-methyl transferase. British journal of pharmacology, 1999, Volume: 126, Issue:7 Topics: Animals; Benzylidene Compounds; Carbidopa; Catalepsy; Catechol O-Methyltransferase Inhibitors; Enzyme Inhibitors; Levodopa; Male; Mice; Motor Activity; Nitro Compounds; Rats; Rats, Sprague-Dawley; Reserpine; Vinyl Compounds	1999
Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride. Pharmacology, biochemistry, and behavior, 1999, Volume: 64, Issue:2 Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Discrimination, Psychological; Dopamine Agents; Dopamine Agonists; Exploratory Behavior; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Proline; Rats; Rats, Wistar; Stereotyped Behavior; Sulpiride; Tyrosine	1999
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology, 1999, Volume: 147, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Caffeine; Catalepsy; Dopamine Agents; Hypokinesia; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenethylamines; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Reserpine; Theophylline	1999
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved? Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:11-12 Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Fluphenazine; Haloperidol; Hyperkinesis; Levodopa; Locomotion; Male; Naphthalenes; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Tetrahydronaphthalenes	1999
Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors. Experimental neurology, 2000, Volume: 163, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Haloperidol; Levodopa; Macaca mulatta; Male; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Inbred F344; Reaction Time; Receptors, N-Methyl-D-Aspartate	2000
The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics. British journal of pharmacology, 1979, Volume: 67, Issue:2 Topics: Animals; Antipsychotic Agents; Atropine; Biogenic Amines; Brain Chemistry; Catalepsy; Humans; Levodopa; Male; Mice; Parasympatholytics; Parasympathomimetics; Rats; Serotonin; Time Factors	1979
Cataleptic effect of 61-91 beta-lipotropic hormone in rat. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1977, Volume: 4, Issue:1 Topics: 5-Hydroxytryptophan; Animals; beta-Lipotropin; Catalepsy; Catatonia; Dose-Response Relationship, Drug; Humans; Levodopa; Naloxone; Rats; Sheep; Tremor	1977
Abolition of oxotremorine effects by L-DOPA pretreatment. Neuropharmacology, 1979, Volume: 18, Issue:7 Topics: Animals; Catalepsy; Diarrhea; Dose-Response Relationship, Drug; Drug Interactions; Humans; Levodopa; Male; Mice; Oxotremorine; Tears; Tremor	1979
Stereotaxic lesions and movement disorders in monkeys. Advances in neurology, 1975, Volume: 10 Topics: Animals; Brain; Brain Mapping; Butyrophenones; Catalepsy; Catatonia; Cerebellum; Chorea; Haplorhini; Humans; Hypothalamus, Posterior; Levodopa; Mesencephalon; Methyltyrosines; Monoamine Oxidase Inhibitors; Motor Cortex; Movement Disorders; Parasympatholytics; Phenothiazines; Pons; Reserpine; Stereotaxic Techniques; Substantia Nigra; Tremor	1975
Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy. Archivum immunologiae et therapiae experimentalis, 1976, Volume: 24, Issue:2 Topics: Amantadine; Animals; Anthracenes; Catalepsy; Drug Synergism; Female; Humans; Levodopa; Male; Physostigmine; Piperidines; Rats; Receptors, Drug; Reserpine; Serotonin; Tranquilizing Agents	1976
[Facilitation of the effects of L-DOPA by alpha-methyldopa]. Biulleten' eksperimental'noi biologii i meditsiny, 1976, Volume: 81, Issue:3 Topics: Animals; Blood Pressure; Catalepsy; Cats; Dopamine; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Levodopa; Male; Methyldopa; Mice; Nictitating Membrane; Reserpine	1976
[Behavioral pharmacology of a new antidepressant, lopramine]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1976, Volume: 72, Issue:5 Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Avoidance Learning; Blepharoptosis; Body Temperature; Catalepsy; Dibenzazepines; Drug Synergism; Emotions; Humans; Imipramine; Lethal Dose 50; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxation; Oxotremorine; Physostigmine; Rats; Stereotyped Behavior	1976
On the role of storage granules in the functional utilization of newly synthesized dopamine. Journal of neural transmission, 1976, Volume: 39, Issue:1-2 Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Catalepsy; Corpus Striatum; Dopamine; Female; Humans; Levodopa; Methyltyrosines; Rats	1976
[Behavior pharmacology of maprotiline, a new antidepressant]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1975, Volume: 71, Issue:8 Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine	1975
[Pharmacological effects of the novel dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on the central nervous system]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1991, Volume: 98, Issue:2 Topics: Animals; Barbiturates; Body Temperature; Catalepsy; Dogs; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Haloperidol; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Rabbits; Rats; Rats, Inbred Strains; Sleep; Tremor; Tremorine	1991
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons. Agents and actions, 1991, Volume: 33, Issue:1-2 Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl	1991
Further studies on the neuroleptic profile of manassantin A. European journal of pharmacology, 1990, Apr-25, Volume: 179, Issue:3 Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Blepharoptosis; Body Temperature; Catalepsy; Furans; Haloperidol; In Vitro Techniques; Levodopa; Lignans; Male; Mice; Norepinephrine; Pentobarbital; Physostigmine; Plants, Medicinal; Stereotyped Behavior	1990
Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:2 Topics: Animals; Antipsychotic Agents; Benzophenones; Catalepsy; Catechol O-Methyltransferase; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Levodopa; Male; Mice; Motor Activity; Nitrophenols; Nomifensine; Parkinson Disease; Rats; Rats, Inbred Strains; Stereotyped Behavior; Tolcapone	1990
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents. Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:2 Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Levodopa; Male; Methamphetamine; Microinjections; Parkinson Disease; Rats; Sulpiride	1990
Dopaminergic drugs influence the intensity of catalepsy induced by microinjections of carbachol into the reticular formation. Neuroscience letters, 1990, Nov-13, Volume: 119, Issue:2 Topics: Animals; Apomorphine; Brain Stem; Carbachol; Catalepsy; Dopamine Agents; Haloperidol; Injections; Injections, Subcutaneous; Levodopa; Male; Microinjections; Motor Activity; Rats; Rats, Inbred Strains; Reticular Formation; Stereotyped Behavior	1990
The effect of neurotransmitters on cataleptic behavior induced by PG D2 in rats. Pharmacology, biochemistry, and behavior, 1987, Volume: 26, Issue:3 Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Catalepsy; Dopamine; Fenclonine; Injections, Intraventricular; Levodopa; Male; Motor Activity; Neurotransmitter Agents; Norepinephrine; Prostaglandin D2; Prostaglandins D; Rats; Rats, Inbred Strains; Serotonin; Time Factors	1987
Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferase. Journal of neural transmission, 1987, Volume: 70, Issue:3-4 Topics: Animals; Behavior, Animal; Catalepsy; Catechol O-Methyltransferase Inhibitors; Central Nervous System; Haloperidol; Levodopa; Male; Motor Activity; Phenethylamines; Propiophenones; Rats; Selegiline; Specific Pathogen-Free Organisms	1987
Stress by restraining potentiates morphine catalepsy in rats. Experientia, 1985, Dec-15, Volume: 41, Issue:12 Topics: 5,6-Dihydroxytryptamine; Animals; Benserazide; Catalepsy; Diclofenac; Ditiocarb; Drug Interactions; Fenclonine; Hemicholinium 3; Levodopa; Male; Mefenamic Acid; Morphine; Naloxone; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological	1985
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:1 Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior	1987
Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate. Neuropharmacology, 1987, Volume: 26, Issue:7A Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain; Callitrichinae; Catalepsy; Dopamine; Dopamine Antagonists; Haloperidol; Injections; Ketotifen; Levodopa; Male; Motor Activity; Nucleus Accumbens; Pyridines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior	1987
[Emetic and catalepsy-inducing actions of buflomedil]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1988, Volume: 92, Issue:6 Topics: Administration, Oral; Animals; Bromocriptine; Catalepsy; Dogs; Domperidone; Dose-Response Relationship, Drug; Levodopa; Male; Mice; Pyrrolidines; Vomiting	1988
Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin. Pharmacological research communications, 1987, Volume: 19, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Levodopa; Male; Neurons; Pterins; Rats; Rats, Inbred Strains; Reserpine	1987
Differential changes in dopaminergic receptor sensitivity induced by agonist drugs. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1985, Volume: 18, Issue:4 Topics: Animals; Apomorphine; Benserazide; Brain Chemistry; Catalepsy; Drug Therapy, Combination; Haloperidol; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine	1985